SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares are facing a sharp sell-off despite delivering a strong quarterly earnings beat, as investors react negatively to management's warnings about search traffic volatility and its reliance on external platforms. The community is deeply divided, with many traders viewing the decline as an overreaction and a buying opportunity for a cash-flow-positive business, while others are fueling bearish sentiment with criticism regarding site moderation, platform culture, and competitive risks from AI.

Flutter Entertainment Plc engages in the business of online betting and gaming. It operates through the following segments: UK and Ireland, Australia, International, and US. The UK and Ireland segment includes the operations of Sky Betting and Gaming, Paddy Power, Betfair, and tombola. The Australia segment focuses on sports betting services provided to Australian customers online. The International segment relates to poker, casino, rummy, lottery, and sports betting. The US segment includes sports betting, daily fantasy sports, and gaming services. The company was founded in 1988 and is headquartered in New York, NY.

Flutter Entertainment Plc

Flutter Entertainment is experiencing a divergence in sentiment as market participants debate its long-term value against competitive pressures from emerging prediction markets. While the stock has seen significant recent volatility, investor attention remains focused on the potential for a rebound driven by a strong international presence and upcoming global sports events.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed momentum driven by community-led buying efforts and discussions around potential supply burns. Market participants remain polarized, with some tracking bullish breakout patterns and whales accumulating, while others warn of retail sentiment-driven volatility and long-term supply challenges.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors weigh significant short interest against ongoing share repurchases and strategic growth initiatives, including international expansion and autonomous vehicle partnerships. Community discourse centers on debates over valuation, the competitive landscape with Uber, and anticipation surrounding upcoming earnings catalysts.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Bausch Health is trending as investors react to a significant acquisition in the liver disease treatment market and persistent speculation surrounding the potential separation or strategic monetization of its Bausch + Lomb asset. While the community remains divided over the companys heavy debt load and past share performance, recent insider buying by key board members has sparked renewed discussions about a potential turnaround.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

The community is actively focused on capturing monthly income from JPMorgan Nasdaq Equity Premium Income ETF as investors look for reliable cash flow in volatile markets. Discussion centers around dividend payout schedules, reinvestment strategies through DRIP, and comparisons with similar income-focused ETFs as traders navigate market chop and volatility.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing significant market activity as investors weigh a recent legal challenge against Eli Lilly's advertising claims alongside strong adoption of the Wegovy oral pill. Community sentiment remains focused on the company's long-term cardiovascular and diabetes market dominance, with many participants viewing recent price volatility as a potential entry opportunity ahead of upcoming earnings reports.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen is experiencing high volatility as investors weigh the commercial rollout of Papzimeos against competitive uncertainty from Inovio's HPV program and broader biotech sector pressure. While the community is actively debating the impact of upcoming quarterly earnings and the long-term potential of the AdenoVerse platform, sentiment remains split between bullish investors focused on institutional accumulation and bearish traders reacting to recent price drops and insider selling.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is experiencing significant volatility and downward pressure as investors weigh news of potential acquisition talks for Delivery Hero against concerns about its autonomous vehicle partnership and broader market sentiment. The community remains divided between long-term bullish sentiment regarding the company's platform scaling and frustration over consistent intraday sell-offs.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is seeing intense community debate as the stock faces downward pressure, with investors weighing concerns over rising operational costs and intense retail competition against bullish sentiment regarding its defensive role and AI-driven efficiency gains. While some participants track recent institutional call-buying and positive price-action pivots, others remain skeptical, focusing on potential headwinds from consumer discretionary spending trends and shifting retail dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CVM @JohnHale6  
If someone believes “Multikine alone could cure cancer in 2–3 months”, then the burden of proof is enormous. To demonstrate that, CEL‑SCI would need to run a completely new, standalone clinical program, because Multikine has never been tested as a monotherapy. 
 
We are talking about at least 5–8 years and roughly $200 million USD in development costs!

StockTwits Web

Cel-Sci Corp

  
If someone believes “Multikine alone could cure cancer in 2–3 months”, then the burden of proof is enormous. To demonstrate that, CEL‑SCI would need to run a completely new, standalone clinical program, because Multikine has never been tested as a monotherapy. 
 
We are talking about at least 5–8 years and roughly $200 million USD in development costs!

Change It

@DeepThought @JohnHale6 Nobody of any importance has said &#39;it cures cancer&#39;.
It&#39;s a &#39;treatment for cancer&#39;.

StockTwits For Android 

 Nobody of any importance has said 'it cures cancer'.
It's a 'treatment for cancer'.